Effect of the remodeling of a glycoantigen on natural killer cell-mediated direct cytotoxicity.
Nakai
R
R
Division of Organ Transplantation, Biomedical Research Center, Osaka University Graduate School of Medicine, Osaka, Japan.
Miyagawa
S
S
Matsunami
K
K
Yamada
M
M
Koma
M
M
Taniguchi
N
N
Shirakura
R
R
D000818:Animals; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D004730:Endothelium, Vascular / Q000276:immunology*; D000939:Epitopes / Q000276:immunology / Q000378:metabolism; D005700:Galactosyltransferases / Q000378:metabolism; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D017351:N-Acetylglucosaminyltransferases / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D012799:Sialyltransferases / Q000378:metabolism; D013552:Swine; D014312:Trisaccharides / Q000276:immunology* / Q000378:metabolism; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase
D000939:Epitopes; D011994:Recombinant Proteins; D014312:Trisaccharides; C076569:alpha-galactosyl epitope; D005700:Galactosyltransferases; D017351:N-Acetylglucosaminyltransferases; C066287:UDP-GlcNAc-Gb(5)Cer beta1-6N-acetylglucosaminyltransferase; C047006:N-acetyllactosaminide alpha-1,3-galactosyltransferase; D012799:Sialyltransferases; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase